Stocks
Moderna (MRNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 51.5% | 51.8% | -47.9% | -106.1% | -131.3% | -132.9% | ||
| Changes by years, y/y, % | -25pp | +0pp | -100pp | -58pp | -25pp | -13.2% | |||
Moderna. EBITDA margin, %
Moderna. EBITDA margin, changes, pp
Moderna (MRNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -863.6% | -535.2% | -13.3% | -108.0% | -341.6% | -132.9% | |
| Changes by years, y/y, % | -191pp | +22pp | -18pp | +9pp | +522pp | |||
| Changes by quarters, q/q, % | -747pp | +328pp | +522pp | -95pp | -234pp | |||
